Neuromuscular Disorders
FDA/CDC
Myasthenia gravis drug gets FDA nod
Rozanolixizumab is the first FDA-approved treatment for adults with both subtypes.
Conference Coverage
U.S. incidence, prevalence of myasthenia gravis is rising
These new estimates are “significantly higher” than those from a prior U.S. analysis from 2003.
Conference Coverage
Therapy to reverse muscle dystrophies shows promise
Interim study data showed rapid reductions in multiple biomarkers of muscle injury, reductions in anti-inflammatory markers, proteomic changes...
From the Journals
Childhood trauma tied to increased Parkinson’s disease severity
The relationship between childhood trauma and PD appears to be dose dependent, new research shows.
Feature
Physician pleads guilty to 52 counts in opioid scheme
The neuromuscular medicine specialist also admitted to ignoring patient requests to lower dosages and signs that patients were selling prescribed...
Commentary
What’s new in brain health?
A new study shows that nonmedical treatment is effective in people with frequent episodic and chronic tension-type headache.
News
Three wild technologies about to change health care
Now, in the 23rd year of the 21st century, you might not believe what we’ll be capable of next.
Literature Review
High drug costs exclude most neurology patients from cutting-edge treatment
“Our study of people with neurologic conditions found that fewer than 20% were being treated with new medications.”
Latest News
AAP issues clinical update to cerebral palsy guidelines
Pediatricians urged to formalize standard developmental screens, refer motor delays early.
From the Journals
Children with autism show distinct brain features related to motor impairment
White matter in the brains of children with autism found to be distinct from the white matter in children with developmental coordination disorder...
Guidelines
First recommendations for cancer screening in myositis issued
The guideline, based on data from a systematic review and meta-analysis and on consensus from an international team of experts and patients,...